| 1 |
32022434 | Visual spatial learning outcomes for clinical trials in neurofibromatosis type 1. | 2020 Feb |
1 |
| 2 |
27081657 | A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I. | 2016 Apr |
2 |
| 3 |
27565148 | Impaired synaptic plasticity in RASopathies: a mini-review. | 2016 Oct |
1 |
| 4 |
27956565 | Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1. | 2016 Dec 13 |
4 |
| 5 |
26562280 | Type 1 neurofibromatosis (von Recklinghausen disease). | 2015 Sep |
1 |
| 6 |
24088225 | Lovastatin improves impaired synaptic plasticity and phasic alertness in patients with neurofibromatosis type 1. | 2013 Oct 2 |
3 |
| 7 |
22433254 | Lovastatin regulates brain spontaneous low-frequency brain activity in neurofibromatosis type 1. | 2012 Apr 25 |
2 |
| 8 |
21850405 | Therapeutics for childhood neurofibromatosis type 1 and type 2. | 2011 Dec |
1 |
| 9 |
21907886 | Lovastatin as treatment for neurocognitive deficits in neurofibromatosis type 1: phase I study. | 2011 Oct |
4 |
| 10 |
20200958 | Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts. | 2010 Jul |
2 |